Abstract
This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.
Cite
CITATION STYLE
APA
Sargent, D. J., Shi, Q., Flowers, C. R., Schmitz, N., Habermann, T. M., … Coiffier, B. (2017). The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project. The Oncologist, 22(12), 1415–1418. https://doi.org/10.1634/theoncologist.2017-0177
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free